Abstract:Circulation Research, Ahead of Print. Background:Vascular BK channel, composed of the large conductance Ca2+-activated K+channel αsubunit and the large conductance Ca2+-activated K+channel β1 subunits, is a key determinant of coronary vasorelaxation and its function is impaired in diabetic vessels. However, our knowledge of diabetic BK channel dysregulation is incomplete. The Sorbin homology and Sorbs2 (SH3 [Src homology 3] domain-containing protein 2) are ubiquitously expressed in arteries, but its role in vascular pathophysiology is unknown.Methods:The role of Sorbs2 in regulating vascular BK channel activity was determined using patch-clamp recordings, molecular biological techniques, and in silico analysis.Results:Sorbs2 is not only a cytoskeletal protein but also an RNA-binding protein that binds to BK channel proteins and theKcnma1(encoding the large conductance Ca2+-activated K+channel αsubunit) mRNA, regulating BK channel expression and function in coronary smooth muscle cells. Molecular biological studies reveal that the SH3 domain of Sorbs2 is necessary for Sorbs2 interaction with the large conductance Ca2+-activated K+channel αsubunit, while both the SH3 and Sorbin homology domains of Sorbs2 interact with the large conductance Ca2+-activated K+channel β1 subunit. Deletion of the SH3 or Sorbin homology domains abolishes the Sorbs2 effect on the large conductance Ca2+-activated K+channel αsubunit/the large conductance Ca2+-activated K+channel β1 subunit current density. Additionally,Sorbs2is a target gene of the Nrf2 (nuclear factor erythroid-2-related factor 2), which binds to the promoter ofSorbs2and regulates Sorbs2 expression in coronary smooth muscle cells. In vivo studies demonstrate thatSorbs2knockout mice at 4 months of age display a significant decrease in BK channel expression and function, accompanied by impaired BK channel Ca2+-sensitivity and BK channel-mediated vasodilation in coronary arteries, without altering their body weights and blood glucose levels. Importantly, Sorbs2 expression is significantly downregulated in the coronary arteries of db/db type 2 diabetic mice.Conclusions:Sorbs2, a downstream target of Nrf2, plays an important role in regulating BK channel expression and function in vascular smooth muscle cells. Vascular Sorbs2 is downregulated in diabetes. Genetic knockout ofSorbs2manifests coronary BK channelopathy and vasculopathy observed in diabetic mice, independent of obesity and glucotoxicity.

Elevated sorbitol underlies a heritable neuropathy

Biallelic mutations in sord are a common cause of potentially treatable genetic neuropathy

Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes

A medical odyssey of a 72‐year‐old man with Charcot–Marie–Tooth disease type 2 newly diagnosed with biallelic variants in SORD gene causing sorbitol dehydrogenase deficiency

SORD-deficient rats develop a motor-predominant peripheral neuropathy unveiling novel pathophysiological insights

A potent sorbitol dehydrogenase inhibitor exacerbates sympathetic autonomic neuropathy in rats with streptozotocin-induced diabetes

Expanding the genetic and clinical spectrum of SORD‐related peripheral neuropathy by reporting a novel variant c.210T>G and evidence of subclinical muscle involvement

Clinical and Genetic Features of Biallelic Mutations in SORD in a Series of Chinese Patients With Charcot-Marie-Tooth and Distal Hereditary Motor Neuropathy

Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study

Long read sequencing overcomes challenges in the diagnosis of SORD neuropathy

Effect of Blood Sugar Control on the Accumulation of Sorbitol and Fructose in Nervous Tissues

Biallelic SORD pathogenic variants cause Chinese patients with distal hereditary motor neuropathy

Tackling sorbitol intolerance

Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats

Exploratory analysis of lower limb muscle MRI in a case series of patients with SORD neuropathy

Juvenile amyotrophic lateral sclerosis associated with biallelic c.757delG mutation of sorbitol dehydrogenase gene

ELEVATED PLASMA SORBITOL LEVELS IN CATARACT PATIENTS WITH SORBITOL DEHYDROGENASE DEFICIENCY

Evaluation of SORD mutations as a novel cause of Charcot‐Marie‐Tooth disease

Sorbs2 Deficiency and Vascular BK Channelopathy in Diabetes

Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency

Demyelination in hereditary sensory neuropathy type‐1C